178 related articles for article (PubMed ID: 20516441)
1. Accumulation of segmental alterations determines progression in neuroblastoma.
Schleiermacher G; Janoueix-Lerosey I; Ribeiro A; Klijanienko J; Couturier J; Pierron G; Mosseri V; Valent A; Auger N; Plantaz D; Rubie H; Valteau-Couanet D; Bourdeaut F; Combaret V; Bergeron C; Michon J; Delattre O
J Clin Oncol; 2010 Jul; 28(19):3122-30. PubMed ID: 20516441
[TBL] [Abstract][Full Text] [Related]
2. Overall genomic pattern is a predictor of outcome in neuroblastoma.
Janoueix-Lerosey I; Schleiermacher G; Michels E; Mosseri V; Ribeiro A; Lequin D; Vermeulen J; Couturier J; Peuchmaur M; Valent A; Plantaz D; Rubie H; Valteau-Couanet D; Thomas C; Combaret V; Rousseau R; Eggert A; Michon J; Speleman F; Delattre O
J Clin Oncol; 2009 Mar; 27(7):1026-33. PubMed ID: 19171713
[TBL] [Abstract][Full Text] [Related]
3. Loss in chromosome 11q identifies tumors with increased risk for metastatic relapses in localized and 4S neuroblastoma.
Spitz R; Hero B; Simon T; Berthold F
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3368-73. PubMed ID: 16740759
[TBL] [Abstract][Full Text] [Related]
4. Analysis of genomic alterations in neuroblastoma by multiplex ligation-dependent probe amplification and array comparative genomic hybridization: a comparison of results.
Combaret V; Iacono I; Bréjon S; Schleiermacher G; Pierron G; Couturier J; Bergeron C; Blay JY
Cancer Genet; 2012 Dec; 205(12):657-64. PubMed ID: 23265803
[TBL] [Abstract][Full Text] [Related]
5. Unequivocal delineation of clinicogenetic subgroups and development of a new model for improved outcome prediction in neuroblastoma.
Vandesompele J; Baudis M; De Preter K; Van Roy N; Ambros P; Bown N; Brinkschmidt C; Christiansen H; Combaret V; Lastowska M; Nicholson J; O'Meara A; Plantaz D; Stallings R; Brichard B; Van den Broecke C; De Bie S; De Paepe A; Laureys G; Speleman F
J Clin Oncol; 2005 Apr; 23(10):2280-99. PubMed ID: 15800319
[TBL] [Abstract][Full Text] [Related]
6. Improved survival of children with neuroblastoma between 1979 and 2005: a report of the Italian Neuroblastoma Registry.
Haupt R; Garaventa A; Gambini C; Parodi S; Cangemi G; Casale F; Viscardi E; Bianchi M; Prete A; Jenkner A; Luksch R; Di Cataldo A; Favre C; D'Angelo P; Zanazzo GA; Arcamone G; Izzi GC; Gigliotti AR; Pastore G; De Bernardi B
J Clin Oncol; 2010 May; 28(14):2331-8. PubMed ID: 20351331
[TBL] [Abstract][Full Text] [Related]
7. ArrayCGH-based classification of neuroblastoma into genomic subgroups.
Michels E; Vandesompele J; De Preter K; Hoebeeck J; Vermeulen J; Schramm A; Molenaar JJ; Menten B; Marques B; Stallings RL; Combaret V; Devalck C; De Paepe A; Versteeg R; Eggert A; Laureys G; Van Roy N; Speleman F
Genes Chromosomes Cancer; 2007 Dec; 46(12):1098-108. PubMed ID: 17823929
[TBL] [Abstract][Full Text] [Related]
8. Two cases of localized neuroblastoma with multiple segmental chromosomal alterations and metastatic progression.
Morales La Madrid A; Nall MB; Ouyang K; Minor A; Raca G; Kent P; Miller I; Schleiermacher G; Janoueix-Lerosey I; Cohn SL
Pediatr Blood Cancer; 2013 Feb; 60(2):332-5. PubMed ID: 22997192
[TBL] [Abstract][Full Text] [Related]
9. Genetic aberrations in prostate carcinoma detected by comparative genomic hybridization and microsatellite analysis: association with progression and angiogenesis.
Strohmeyer DM; Berger AP; Moore DH; Bartsch G; Klocker H; Carroll PR; Loening SA; Jensen RH
Prostate; 2004 Apr; 59(1):43-58. PubMed ID: 14991865
[TBL] [Abstract][Full Text] [Related]
10. Deletions in chromosome arms 3p and 11q are new prognostic markers in localized and 4s neuroblastoma.
Spitz R; Hero B; Ernestus K; Berthold F
Clin Cancer Res; 2003 Jan; 9(1):52-8. PubMed ID: 12538451
[TBL] [Abstract][Full Text] [Related]
11. Favorable outcome of triploid neuroblastomas: a contribution to the special oncogenesis of neuroblastoma.
Spitz R; Betts DR; Simon T; Boensch M; Oestreich J; Niggli FK; Ernestus K; Berthold F; Hero B
Cancer Genet Cytogenet; 2006 May; 167(1):51-6. PubMed ID: 16682287
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of neuronal genes defines subtypes of disseminated neuroblastoma with favorable and unfavorable outcome.
Fischer M; Oberthuer A; Brors B; Kahlert Y; Skowron M; Voth H; Warnat P; Ernestus K; Hero B; Berthold F
Clin Cancer Res; 2006 Sep; 12(17):5118-28. PubMed ID: 16951229
[TBL] [Abstract][Full Text] [Related]
13. [Genetic alterations in neuroblastoma and their usefulness for clinical management].
Normand C; Michon J; Janoueix-Lerosey I; Delattre O; Schleiermacher G
Bull Cancer; 2011 May; 98(5):477-88. PubMed ID: 21609891
[TBL] [Abstract][Full Text] [Related]
14. Distal chromosome 17 gains in neuroblastomas detected by comparative genomic hybridization (CGH) are associated with a poor clinical outcome.
Brinkschmidt C; Christiansen H; Terpe HJ; Simon R; Lampert F; Boecker W; Dockhorn-Dworniczak B
Med Pediatr Oncol; 2001 Jan; 36(1):11-3. PubMed ID: 11464859
[TBL] [Abstract][Full Text] [Related]
15. Numerical and structural aberrations in advanced neuroblastoma tumours by CGH analysis; survival correlates with chromosome 17 status.
Cunsolo CL; Bicocchi MP; Petti AR; Tonini GP
Br J Cancer; 2000 Nov; 83(10):1295-300. PubMed ID: 11044353
[TBL] [Abstract][Full Text] [Related]
16. Oligonucleotide array-based comparative genomic hybridization (aCGH) of 90 neuroblastomas reveals aberration patterns closely associated with relapse pattern and outcome.
Spitz R; Oberthuer A; Zapatka M; Brors B; Hero B; Ernestus K; Oestreich J; Fischer M; Simon T; Berthold F
Genes Chromosomes Cancer; 2006 Dec; 45(12):1130-42. PubMed ID: 16958102
[TBL] [Abstract][Full Text] [Related]
17. Determination of 17q gain in patients with neuroblastoma by analysis of circulating DNA.
Combaret V; Bréjon S; Iacono I; Schleiermacher G; Pierron G; Ribeiro A; Bergeron C; Marabelle A; Puisieux A
Pediatr Blood Cancer; 2011 May; 56(5):757-61. PubMed ID: 21370407
[TBL] [Abstract][Full Text] [Related]
18. Genomic Copy Number Profiling Using Circulating Free Tumor DNA Highlights Heterogeneity in Neuroblastoma.
Chicard M; Boyault S; Colmet Daage L; Richer W; Gentien D; Pierron G; Lapouble E; Bellini A; Clement N; Iacono I; Bréjon S; Carrere M; Reyes C; Hocking T; Bernard V; Peuchmaur M; Corradini N; Faure-Conter C; Coze C; Plantaz D; Defachelles AS; Thebaud E; Gambart M; Millot F; Valteau-Couanet D; Michon J; Puisieux A; Delattre O; Combaret V; Schleiermacher G
Clin Cancer Res; 2016 Nov; 22(22):5564-5573. PubMed ID: 27440268
[TBL] [Abstract][Full Text] [Related]
19. Loss of whole chromosome X predicts prognosis of neuroblastoma patients with numerical genomic profile.
Parodi S; Pistorio A; Erminio G; Ognibene M; Morini M; Garaventa A; Gigliotti AR; Haupt R; Frassoni F; Pezzolo A
Pediatr Blood Cancer; 2019 May; 66(5):e27635. PubMed ID: 30688024
[TBL] [Abstract][Full Text] [Related]
20. Survival analysis of clinical, pathologic, and genetic features in neuroblastoma presenting as locoregional disease.
Mora J; Cheung NK; Chen L; Qin J; Gerald W
Cancer; 2001 Jan; 91(2):435-42. PubMed ID: 11180092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
